• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Intralesional bleomycin versus intralesional triamcinolone in the treatment of keloids and hypertrophic scars
This article is protected by copyright. All rights reserved.PMID:35871490 | DOI:10.1111/dth.15730
Source: Pain Physician - July 24, 2022 Category: Anesthesiology Authors: Hamideh Moravej Ali Forghanian Sahar Dadkhahfar Nikoo Mozafari Source Type: research

Management of neurotoxicity following CAR-T cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bull Cancer. 2022 Jan 27:S0007-4551(22)00013-3. doi: 10.1016/j.bulcan.2021.12.013. Online ahead of print.ABSTRACTThe immune effector cell-associated syndrome (ICANS) has been described as the second most frequent specific complication following CAR-T cell therapy. The median time to the onset of neurological symptoms is five days after CAR-T infusion. ICANS can be concomitant to cytokine release syndrome but often follows the resolution of the latter. However, 10 % of patients experience delayed onset after 3 weeks of CAR-T cell infusion. The duration of symptoms is usually short, around five days if an early appropriate t...
Source: Bulletin du Cancer - January 31, 2022 Category: Cancer & Oncology Authors: Muriel Picard Arthur Sterin Jacques-Olivier Bay Corinne Courbon Anne-Sophie Moreau Franciane Paul C écile Pochon Jean-Jacques Tudesq C éline Vicente Mathilde Yakoub-Agha Ibrahim Yakoub-Agha Source Type: research

Recommendations for COPD management in Central and Eastern Europe
Expert Rev Respir Med. 2022 Jan 10. doi: 10.1080/17476348.2021.2023498. Online ahead of print.ABSTRACTINTRODUCTION: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report provides guidance on effective management of chronic obstructive pulmonary disease (COPD) according to local healthcare systems. However, COPD is a heterogenous disease and certain aspects, including prevalence, disease-time course and phenotype distribution, can differ between countries. Moreover, features of clinical practice and healthcare systems for COPD patients can vary widely, even in geographically close and economicall...
Source: Respiratory Care - January 10, 2022 Category: Respiratory Medicine Authors: Arschang Valipour Zaurbek Aisanov Sergey Avdeev Vladimir Koblizek Ivan Kocan Ivan Kopitovic Gergely Lupkovics Milena Man Maris Bukovskis Neven Tudoric Marija Vukoja Wojciech Naumnik Nikolay Yanev Source Type: research

Management of cytokine release syndrome and macrophage activation syndrome following CAR-T cell therapy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bull Cancer. 2021 Dec 8:S0007-4551(21)00447-1. doi: 10.1016/j.bulcan.2021.11.002. Online ahead of print.ABSTRACTThe use of chimeric antigen receptor T cells (CAR-T) has increased since their approval in the treatment of several relapsed/refractory B cell malignancies. The management of their specific toxicities, such as cytokine release syndrome (CRS), tends to be better understood and well-defined. During the twelfth edition of practice harmonization workshops of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC), a working group focused its work on the management of patients developing ...
Source: Bulletin du Cancer - December 13, 2021 Category: Cancer & Oncology Authors: Jean-Jacques Tudesq Mathilde Yakoub-Agha Jacques-Olivier Bay Corinne Courbon Franciane Paul Muriel Picard C écile Pochon Arthur Sterin C éline Vicente Emmanuel Canet Ibrahim Yakoub-Agha Anne-Sophie Moreau Source Type: research

Management of patients developing acute gastro-intestinal graft-versus-host-disease: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bull Cancer. 2021 May 6:S0007-4551(21)00118-1. doi: 10.1016/j.bulcan.2021.01.013. Online ahead of print.ABSTRACTGraft-versus-host disease (GVHD) is the most common complication after allogeneic hematopoietic cell transplantation (allo-HCT) with a frequency range of 30% to 50%. GVH is the leading cause of non-relapse-related deaths and a cause early mortality. Gastro-intestinal (GI) GVH results in digestive manifestations that involve the small intestine and the colon. The patient may then have diarrhea, intestinal bleeding, abdominal pain but also clinical signs such as nausea and vomiting may lead to anorexia. GI-GVHD pro...
Source: Bulletin du Cancer - May 10, 2021 Category: Cancer & Oncology Authors: Eva de Berranger Amandine Charbonnier Elise Davy Caroline Dendonker Virginie Denis D éborah Desmier Carole Farrugia Sarah Guenounou Yoann Guilbert Edgar Jost Alexandra L'hostette Fanny Rialland Sophie Taque Nabil Yafour David Seguy Ibrahim Yakoub Agha Source Type: research

How we developed, at the Centre/Institute for Neuromuscular Diseases, differential diagnostics of Spinal Muscle Atrophies / Amyotrophic Lateral Sclerosis (SMA/ALS) and tried to influence the development of the disease.
Authors: Jušić A Abstract In our research, we placed the emphasis on delimiting fatal diseases against those that have some similar symptoms, but can be improved, even completely cured. More often we succeeded in differentiating the local compressive factor. In our search for early symptoms, we also found physiological, although quite unusual EMG phenomena. High amplitude neural potentials confirmed the malignant disease diagnosis. The spinal angiography discovered arterial pathology, while CT demonstrated localised hydromyelia. Amyotrophic syndromes caused by chronic led intoxications represented a separate grou...
Source: Acta Myologica - February 26, 2015 Category: Neurology Tags: Acta Myol Source Type: research